GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines, immunotherapies, and gene therapies PISCATAWAY, N.J. — GenScript Biotech Corporation, a global leader in life science research tools and services, has today announced the expansion of its in vitro transcription […]

LONGMONT, Colo. — KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene Therapy (C&GT) Market, is launching GLP Genomic Integrity Karyotyping services at the 2024 American Society for Gene and Cell Therapy (ASGCT) Meeting in Baltimore, Booth 2217, May 7–11. “This expansion of our best-in-class […]

LFB BIOMANUFACTURING will outsource cell line development service to Sartorius to combine the best of each company’s expertise and increase value for customers  Collaboration provides single-stop solution for customers to speed up protein therapy development  LFB BIOMANUFACTURING specializes in therapeutic protein biomanufacturing, and is an entity of LFB, a leading European company providing plasma-derived medicinal […]

InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert Services provides vaccine manufacturers with tailored workflow solutions to help address and eliminate development bottlenecks and accelerate the analysis and validation of seasonal vaccines and novel biotherapeutics. Expert Services is InDevR’s latest […]

Hamilton Pipetting Excellence Program Boston, MA – Hamilton Company, a pioneer in automated liquid handling systems, is proud to announce the unveiling of the Hamilton Pipetting Excellence Program (HPEP) at the SLAS International Conference & Exhibition taking place February 3-7, 2024, in Boston. This innovative program marks a significant advancement in the safe and compliant […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations […]

The new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US customers Biognosys’ center of excellence for proteomics innovation at its headquarters near Zurich, Switzerland continues to offer its entire portfolio of services for discovery, targeted, and structural proteomics for all regions, including the Americas ZURICH & NEWTON, Massachusetts — Biognosys, […]

Redwood City, CA & Waltham, MA – Synthego, a leading provider of genome engineering solutions, and SeQure Dx, a company focused on off-target analysis for preclinical and clinical gene modification customers, have announced a strategic partnership to provide CRISPR-based therapeutics developers with comprehensive off-target editing analytical services that include best-in-class technology and turn-key end-to-end development solutions. […]

IRVINE, Calif. – Zymo Research, a leading provider of microbiology research tools, proudly announces the official launch of its Metagenome Assembly Analysis Service, utilizing PacBio HiFi sequencing. This groundbreaking service offers researchers an easier way to study intricate microbial communities. While DNA sequencing and assembly have become commonplace, repetitive sequences can cause mis-assemblies and gaps, giving an […]

Genomenon Curate-Pro Leverages Company’s Existing Infrastructure for Curating the Genome Genomenon, a leading genomic intelligence company, today announced the launch of Genomenon Curate-Pro, a rapid on-demand evidence curation and variant classification service for genetic testing labs. Genomenon Curate-Pro service leverages the company’s automation and genetic curation expertise to address the laborious and expensive variant research […]